Results for tag: "Hetlioz"

Hetlioz (tasimelteon) is a drug used to treat Non-24-Hour Sleep-Wake Disorder (Non-24), a rare circadian rhythm disorder that affects the central nervous system. It is the only approved treatment for Non-24, and is available in the United States, Canada, and Europe. Hetlioz works by resetting the body's internal clock, allowing patients to sleep and wake at regular times. It is taken orally once a day, usually at bedtime. The Hetlioz market is a niche market within the larger Central Nervous System Drugs market. It is a relatively small market, but is growing due to increased awareness of Non-24 and the need for effective treatments. Some companies in the Hetlioz market include Vanda Pharmaceuticals, which manufactures and markets the drug, as well as other pharmaceutical companies that are researching and developing treatments for Non-24. Show Less Read more